The weekly litigation news digest is live. Subscribe now

IP Verse

Bonerge Lifescience (Hunan) Co., Ltd. v. Nanjing Nutrabuilding Bio-Tech Co., Ltd. - IPR2025-01593

Explore the PTAB proceeding IPR2025-01593 filed by Bonerge Lifescience (Hunan) Co., Ltd. against Nanjing Nutrabuilding Bio-Tech Co., Ltd. on Sep 26, 2025. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2025-01593
Filing Date
Sep 26, 2025
Petitioner
Bonerge Lifescience (Hunan) Co., Ltd.
Respondent
Nanjing Nutrabuilding Bio-Tech Co., Ltd.
Status
Pending
Respondent Application Number
15491933
Respondent Tech Center
1600
Respondent Patent Number
10278961

Decision Documents New

Decision pending - set alert to receive updates

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Notice: Patent Owner Power of Attorney

Dec 2, 2025PAPERPATENT OWNER

Patent Owner Discretionary Denial Brief

Dec 2, 2025PAPERPATENT OWNER

2001 - Text Only of Complaint in Nanjing Nutrabuilding Bio-Tech Co., Ltd. v. Bonerge Lifescience (Hunan) Co., Ltd.

Dec 2, 2025EXHIBITPATENT OWNER

2002 - Exhibit 11 to Complaint

Dec 2, 2025EXHIBITPATENT OWNER

2003 - Excerpt of Petitioner's Responses to Requests for Admissions in Parallel Litigation

Dec 2, 2025EXHIBITPATENT OWNER

2004 - Exhibit 12 to Complaint

Dec 2, 2025EXHIBITPATENT OWNER

2005 - Petitioner's Amended Answer to Complaint in Parallel Litigation

Dec 2, 2025EXHIBITPATENT OWNER

2006 - Exhibit 13 to Complaint

Dec 2, 2025EXHIBITPATENT OWNER

2007 - Exhibit 14 to Complaint

Dec 2, 2025EXHIBITPATENT OWNER

2008 - Return of Service of Summons and Complaint in Parallel Litigation

Dec 2, 2025EXHIBITPATENT OWNER

2009 - Joint Rule 26(f) Report in Parallel Litigation

Dec 2, 2025EXHIBITPATENT OWNER

2010 - Scheduling Order in Parallel Litigation

Dec 2, 2025EXHIBITPATENT OWNER

2011 - Amended Scheduling Order in Parallel Litigation

Dec 2, 2025EXHIBITPATENT OWNER

2012 - Patent Owner's Preliminary Infringement Contentions in Parallel Litigation

Dec 2, 2025EXHIBITPATENT OWNER

2013 - Declaration of Mark D. Nielsen

Dec 2, 2025EXHIBITPATENT OWNER

2014 - Petitioner's Motion to Stay Brief in Parallel Litigation

Dec 2, 2025EXHIBITPATENT OWNER

2015 - Court Order Denying without prejudice Petitioner's Motion to Stay in Parallel Litigation

Dec 2, 2025EXHIBITPATENT OWNER

2016 - Petitioner's Invalidity Contentions in Parallel Litigation

Dec 2, 2025EXHIBITPATENT OWNER

2017 - Interim Processes for PTAB Workload Management March 26, 2025

Dec 2, 2025EXHIBITPATENT OWNER

2018 - Pound and Bracken - Is animal research sufficiently evidence based to be a cornerstone of biomedical research?

Dec 2, 2025EXHIBITPATENT OWNER

2019 - Small, L. et al, Modeling insulin resistance in rodents by alterations in diet: what have high-fat and high-calorie diets revealed?

Dec 2, 2025EXHIBITPATENT OWNER

2020 - Lai, M. et al - You are what you eat, or are you? The challenges of translating high-fat-fed rodents to human obesity and diabetes

Dec 2, 2025EXHIBITPATENT OWNER

Petitioner's stipulation

Oct 24, 2025EXHIBITBOARD

Notice: Mandatory Notice

Oct 15, 2025PAPERPATENT OWNER

Notice: Notice filing date accorded

Oct 7, 2025PAPERBOARD

Notice: Power of Attorney

Sep 26, 2025PAPERPETITIONER

U.S. Patent No. 10,278,961

Sep 26, 2025EXHIBITPETITIONER

Excerpts of Prosecution File History of U.S. Patent No. 10,278,961

Sep 26, 2025EXHIBITPETITIONER

Nigel Turner et al., Berberine and Its More Biologically Available Derivati

Sep 26, 2025EXHIBITPETITIONER

Shannon Reagan-Shaw et al., Dose translation from animal to human studies r

Sep 26, 2025EXHIBITPETITIONER

Yifei Zhang et al., Treatment of Type 2 Diabetes and Dyslipidemia with the

Sep 26, 2025EXHIBITPETITIONER

Ru Feng et al., Transforming berberine into its intestine-absorbable form b

Sep 26, 2025EXHIBITPETITIONER

Guidance for Industry Estimating the Maximum Safe Starting Dose in Initial

Sep 26, 2025EXHIBITPETITIONER

Chunqiu Chen et al., A randomized clinical trial of berberine hydrochloride

Sep 26, 2025EXHIBITPETITIONER

Li Liu et al., Berberine suppresses intestinal disaccharidases with benefic

Sep 26, 2025EXHIBITPETITIONER

Aillen JF King, The use of animal models in diabetes research, British Jour

Sep 26, 2025EXHIBITPETITIONER

U.S. Application 12/443,401, published on May 6, 2010 as US 2010/0113494. (

Sep 26, 2025EXHIBITPETITIONER

Expert Declaration of Dr. Ronald J. Shebuski, Sr.

Sep 26, 2025EXHIBITPETITIONER

Petition for Inter Partes Review of U.S. Patent 10,278,961

Sep 26, 2025PAPERPETITIONER